{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "currency": "USD", "regularMarketChangePercent": -1.8035544, "regularMarketPrice": 75.68, "earningsTimestamp": 1682973000, "earningsTimestampStart": 1690833600, "earningsTimestampEnd": 1691179200, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.92, "epsForward": 0.07, "epsCurrentYear": -0.51, "priceEpsCurrentYear": -148.39217, "sharesOutstanding": 32553600, "bookValue": 5.921, "fiftyDayAverage": 75.624, "fiftyDayAverageChange": 0.055999756, "fiftyDayAverageChangePercent": 0.00074050244, "twoHundredDayAverage": 59.9716, "twoHundredDayAverageChange": 15.708401, "twoHundredDayAverageChangePercent": 0.26193067, "marketCap": 2548137984, "forwardPE": 1081.1428, "priceToBook": 12.781625, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.8 - Buy", "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1556803800000, "priceHint": 2, "marketState": "PRE", "exchange": "NGM", "shortName": "TransMedics Group, Inc.", "longName": "TransMedics Group, Inc.", "messageBoardId": "finmb_429233", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChange": -1.3899994, "regularMarketTime": 1683921604, "regularMarketDayHigh": 77.495, "regularMarketDayRange": "75.095 - 77.495", "regularMarketDayLow": 75.095, "regularMarketVolume": 554911, "regularMarketPreviousClose": 77.07, "bid": 68.0, "ask": 89.45, "bidSize": 11, "askSize": 8, "fullExchangeName": "NasdaqGM", "financialCurrency": "USD", "regularMarketOpen": 77.07, "averageDailyVolume3Month": 638555, "averageDailyVolume10Day": 1102630, "fiftyTwoWeekLowChange": 51.67, "fiftyTwoWeekLowChangePercent": 2.15202, "fiftyTwoWeekRange": "24.01 - 90.15", "fiftyTwoWeekHighChange": -14.470001, "fiftyTwoWeekHighChangePercent": -0.16051027, "fiftyTwoWeekLow": 24.01, "fiftyTwoWeekHigh": 90.15, "displayName": "TransMedics", "symbol": "TMDX"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "200 Minuteman Road", "address2": "Suite 302", "city": "Andover", "state": "MA", "zip": "01810", "country": "United States", "phone": "978 552 0900", "website": "https://www.transmedics.com", "industry": "Medical Devices", "industryDisp": "Medical Devices", "sector": "Healthcare", "longBusinessSummary": "TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage; and OCS Liver for the preservation of donor livers. The company was founded in 1998 and is headquartered in Andover, Massachusetts.", "fullTimeEmployees": 212, "companyOfficers": [{"maxAge": 1, "name": "Dr. Waleed H. Hassanein M.D.", "age": 54, "title": "Founder, Pres, CEO & Director", "yearBorn": 1968, "fiscalYear": 2022, "totalPay": {"raw": 1461962, "fmt": "1.46M", "longFmt": "1,461,962"}, "exercisedValue": {"raw": 2214915, "fmt": "2.21M", "longFmt": "2,214,915"}, "unexercisedValue": {"raw": 35038700, "fmt": "35.04M", "longFmt": "35,038,700"}}, {"maxAge": 1, "name": "Mr. Stephen  Gordon", "age": 54, "title": "CFO, Treasurer & Sec.", "yearBorn": 1968, "fiscalYear": 2022, "totalPay": {"raw": 744618, "fmt": "744.62k", "longFmt": "744,618"}, "exercisedValue": {"raw": 2548841, "fmt": "2.55M", "longFmt": "2,548,841"}, "unexercisedValue": {"raw": 2006845, "fmt": "2.01M", "longFmt": "2,006,845"}}, {"maxAge": 1, "name": "Dr. Tamer I. Khayal M.D.", "age": 53, "title": "Chief Commercial Officer", "yearBorn": 1969, "fiscalYear": 2022, "totalPay": {"raw": 748778, "fmt": "748.78k", "longFmt": "748,778"}, "exercisedValue": {"raw": 3152904, "fmt": "3.15M", "longFmt": "3,152,904"}, "unexercisedValue": {"raw": 5579405, "fmt": "5.58M", "longFmt": "5,579,405"}}, {"maxAge": 1, "name": "Ms. Miriam C. Provost Ph.D.", "age": 61, "title": "VP of Global Regulatory Affairs", "yearBorn": 1961, "fiscalYear": 2022, "totalPay": {"raw": 535930, "fmt": "535.93k", "longFmt": "535,930"}, "exercisedValue": {"raw": 390248, "fmt": "390.25k", "longFmt": "390,248"}, "unexercisedValue": {"raw": 1664774, "fmt": "1.66M", "longFmt": "1,664,774"}}, {"maxAge": 1, "name": "Mr. Nick  Corcoran", "age": 40, "title": "Sr. VP of Supply Chain & Operations", "yearBorn": 1982, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Mark  Anderson", "title": "Sr. Director of Technology Devel.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Susan  Goodman", "title": "VP of HR", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "auditRisk": 5, "boardRisk": 3, "compensationRisk": 10, "shareHolderRightsRisk": 3, "overallRisk": 6, "governanceEpochDate": 1682899200, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}